P142 ROS101, a Novel Targeted Methotrexate Prodrug, Selectively Activated by Reactive Oxygen Species (ROS) Shows Reduced Toxicity in Rat CIA Model of Rheumatoid Arthritis
doi 10.1136/annrheumdis-2018-ewrr2019.126
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism